98%
921
2 minutes
20
Sarcoidosis (SA) is a granulomatous disorder, which mostly affects the lungs. Its clinical characteristics resemble tuberculosis (TB), but its treatment is different. The etiology of SA is unknown; however, mycobacterial antigens were proposed as environmental factors in its development. Due to previously revealed immunocomplexemia with mycobacterial antigens in the blood of our SA but not TB patients, and in the search for biomarkers for differential diagnosis of the two disorders, we studied the phagocytic activity of monocytes from both patients' groups with flow cytometry. With the use of this method, we also analyzed the occurrence of receptors for IgG (FcγR) and complement components (CR) at the surface of these monocytes, responsible for phagocytosis of immunocomplexes. We revealed a higher phagocytic activity of monocytes in both disorders, but an increased frequency of monocytes with FcγRIII (CD16) and decreased with CR1 (CD35) receptor in the blood of SA vs. TB patients. With regard to our other genetic study on FcγRIII variants in SA and TB, this may account for the decreased clearance of immunocomplexes and different immune responses in the two diseases. Thus, the presented analysis not only sheds light on the pathomechanisms of SA and TB but may also support their differential diagnosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253566 | PMC |
http://dx.doi.org/10.3390/ijms24119713 | DOI Listing |
Proc Natl Acad Sci U S A
September 2025
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461.
The ESX-5 secretion system, uniquely found in slow-growing mycobacteria, is predicted to secrete over 150 proteins across the inner membrane of (). Although many of these substrates are believed to promote virulence, most remain poorly characterized. Here, we use a complete locus deletion strain of ESX-5 in to examine the molecular changes caused by a broad loss in ESX-5 secretory substrates.
View Article and Find Full Text PDFJCI Insight
August 2025
Texas Biomedical Research Institute, San Antonio, United States of America.
To radically diminish TB incidence and mortality by 2035, as set out by the WHO End TB Strategy, there is a desperate need for improved TB therapies and a more effective vaccine against the deadly pathogen Mycobacterium tuberculosis (Mtb). Aerosol vaccination with the MtbΔsigH mutant protects two different species of NHPs against lethal TB challenge by invoking vastly superior T and B cell responses in the lungs through superior antigen-presentation and interferon-conditioning. Since the Geneva consensus on essential steps towards the development of live mycobacterial vaccines recommends that live TB vaccines must incorporate at least two independent gene knock outs, we have now generated several rationally designed, double (DKO)- and triple (TKO) knock-out mutants in Mtb, each containing the ΔsigH deletion.
View Article and Find Full Text PDFFront Immunol
August 2025
Laboratory for Immunogenetics, Central Research Tuberculosis Institute, Moscow, Russia.
Previously we have shown that -congenic recombinant mice of the B6.I-9.3 ( ) strain are significantly more susceptible to tuberculosis (TB) infection compared to their C57BL/6 (B6, ) ancestors.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, SC, CEP-88040-900, Brazil.
Coinfections can alter the adaptive immune responses to bovine tuberculosis (bTB) and hinder accurate diagnosis; however, their effect on host immunity to Mycobacterium bovis and disease progression is not well understood. In this study, we assessed the impact of natural coinfection with bovine leukemia virus (BLV) on immune responses to M. bovis.
View Article and Find Full Text PDFAvian Pathol
August 2025
Immunology Section, ICAR-Indian Veterinary Research Institute, Izatnagar-243122, India.
In the present study, antigen-chitosan-PLGA nanoparticles have been explored as the delivery system for inactivated whole IBD viral antigens. The immunized birds showed the peak antibody level (ELISA titer 4095.65±55.
View Article and Find Full Text PDF